Treatment of CRTH2-mediated diseases and conditions

Assignee

• Oxagen Limited

Inventors

• David Middlemiss (27 patents)
• Mark Richard Ashton (12 patents)
• Edward Andrew Boyd (38 patents)
• Frederick Arthur Brookfield (65 patents)
• Michael George Hunter (22 patents)
• Mark Whittaker (76 patents)
• Chris Palmer (5 patents)
• Eric Roy Pettipher (11 patents)

View full patent text on Google Patents →